INS and Alzheimer disease: Therefore, considering the pathogenic interaction between Aβ and impaired insulin signaling, it is not surprising that central metabolic dysfunction is a certain feature of AD, illustrated by brain glucose hypometabolic changes, in addition to defects in insulin signaling, which usually proceeds AD signs and symptoms by several years [191,192].